Published in FASEB J on July 29, 2015
Functional and molecular insights of hydrogen sulfide signaling and protein sulfhydration. J Mol Biol (2016) 0.80
Abnormally activated one-carbon metabolic pathway is associated with mtDNA hypermethylation and mitochondrial malfunction in the oocytes of polycystic gilt ovaries. Sci Rep (2016) 0.78
Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol Res (2016) 0.77
Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism. Am J Physiol Heart Circ Physiol (2017) 0.75
Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia. Mol Cell Biochem (2017) 0.75
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
MethPrimer: designing primers for methylation PCRs. Bioinformatics (2002) 14.48
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA (1995) 11.45
The DNA methyltransferases of mammals. Hum Mol Genet (2000) 10.66
Perceptions of epigenetics. Nature (2007) 8.43
Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29
5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene (2002) 4.81
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Homocysteine metabolism. Annu Rev Nutr (1999) 3.75
Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med (2010) 3.60
S-Adenosylmethionine and methylation. FASEB J (1996) 3.48
Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int (1984) 3.04
Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol (2003) 2.85
DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. Mol Cell Biol (2007) 2.47
Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J Nutr (2001) 1.79
Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol (2006) 1.79
The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest (1996) 1.76
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A (1994) 1.66
Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol (2000) 1.64
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol (2013) 1.52
Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. Pathol Res Pract (1980) 1.40
Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res (2006) 1.35
Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna) (2004) 1.33
S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A (2004) 1.32
Activity of matrix metalloproteinase-9 against native collagen types I and III. FEBS J (2007) 1.23
Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J Biol Chem (2007) 1.18
Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. Am J Nephrol (2010) 1.16
Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney Int (2012) 1.11
Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta (2010) 1.10
High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation (1997) 1.10
Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem (2005) 1.09
Matrix metalloproteinase-9-mediated type III collagen degradation as a novel serological biochemical marker for liver fibrogenesis. Liver Int (2010) 1.09
Early interstitial changes in hypertension-induced renal injury. Hypertension (1993) 1.07
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant (2006) 1.06
Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr (2003) 1.05
The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis (2003) 1.00
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance. Am J Physiol Endocrinol Metab (2008) 1.00
Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype. Respir Res (2012) 0.99
Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. Int J Cancer (2001) 0.99
Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction. Biochim Biophys Acta (2013) 0.99
Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta (2008) 0.97
Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int (2007) 0.97
Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension (2002) 0.97
Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines. World J Nephrol (2013) 0.94
Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation. Am J Physiol Cell Physiol (2010) 0.94
Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis. Diabetes (2014) 0.93
DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics (2013) 0.92
Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int (2002) 0.91
Homocysteine induces mesangial cell apoptosis via activation of p38-mitogen-activated protein kinase. Kidney Int (2006) 0.90
Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health (2011) 0.90
Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3. Transplantation (2012) 0.89
Differential regulation of DNA methylation versus histone acetylation in cardiomyocytes during HHcy in vitro and in vivo: an epigenetic mechanism. Physiol Genomics (2014) 0.89
Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation. Clin Chem Lab Med (2005) 0.89
DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol Dial Transplant (2014) 0.88
Epigenetic regulation of aortic remodeling in hyperhomocysteinemia. FASEB J (2014) 0.87
Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model. Pathobiology (1998) 0.87
Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells. Toxicol Lett (2010) 0.86
Epigenetics of progression of chronic kidney disease: fact or fantasy? Semin Nephrol (2013) 0.86
Matrix Metalloproteinase Inhibition Mitigates Renovascular Remodeling in Salt-Sensitive Hypertension. Physiol Rep (2013) 0.85
Homocysteine accelerates senescence of endothelial cells via DNA hypomethylation of human telomerase reverse transcriptase. Arterioscler Thromb Vasc Biol (2014) 0.84
A specific HPLC-UV method for the determination of cysteine and related aminothiols in biological samples. Talanta (2003) 0.83
Mouse model for deficiency of methionine synthase reductase exhibits short-term memory impairment and disturbances in brain choline metabolism. Biochem J (2014) 0.82
Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice. J Hypertens (2013) 0.82
Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. J Nephrol (2008) 0.82
Notable epigenetic role of hyperhomocysteinemia in atherogenesis. Lipids Health Dis (2014) 0.82
Epigenetics: a new way to look at kidney diseases. Nephrol Dial Transplant (2014) 0.79
Epigenetic unsilencing reverses renal fibrosis. J Am Soc Nephrol (2014) 0.76